Guangzhou Jiangyuan Medical Technology Co., Ltd. is a high-tech enterprise led by industry experts, with doctors and masters as the backbone of R & D. the company is located in Huangpu Science City, Guangzhou, China.
At present, Guangzhou Jiangyuan has obtained more than 50 invention, utility model patents and software copyrights. It has provided more than 20 types of in vitro diagnostic instruments and reagents for 1000 hospital users throughout the country. It is a professional provider of in vitro diagnostic products for gynecological infections and gynecological tumors. At the same time, Guangzhou Jiangyuan also passed the recognition of high-tech enterprises, the recognition of small giant enterprises in scientific and technological innovation in Guangzhou, the recognition of small and medium-sized enterprises in science and technology, and the certification of enterprise R & D institutions in Guangzhou.
Guangzhou Jiangyuan has more than 4000 square meters of reagent R & D and production base, instrument R & D and production base, 1000 square meters of 100000 level clean workshop, 10000 level and local 100 level microbial testing laboratory. The company has advanced production facilities, complete R & D centers, orderly production and operation centers, and a nationwide sales network and after-sales service center.
For many years, it has been committed to the research and development of gynecological testing products, paying great attention to the scientific research of gynecological diseases, and continuously following up the development of the frontier of women's health. We believe that as long as we make continuous efforts and pursuit, we will surely be able to bring health and welfare to women and protect their health.
Major projects undertaken and participated in：
Guangzhou Jiangyuan participated in the major project of the Ministry of science and technology, science and technology innovation 2030 new generation artificial intelligence major project, with an expenditure of 42 million yuan. The project is led by Professor Zhao Jian of the first hospital of Peking University, and Guangzhou Jiangyuan provides technical support for immune cell labeling. This project is based on artificial intelligence (AI) technology and biological immune cell labeling technology to establish a new standard of cervical cancer screening technology to greatly improve the accuracy of cervical cancer screening.
Guangzhou Jiangyuan full-automatic p16 immunocytochemical system, as a selection method for accurate diagnosis of cervical cancer, participated in the domestic leading phase III clinical trial project of nine valent HPV vaccine sponsored by Jiangsu Ruike / anbaisheng.